Indu Genome Valley Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 10-12-2024
- Paid Up Capital ₹ 1.00 Cr
as on 10-12-2024
- Company Age 16 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2023)
- Profit 100.00%
(FY 2023)
- Ebitda 99.96%
(FY 2023)
- Net Worth 13.24%
(FY 2023)
- Total Assets %
(FY 2023)
About Indu Genome Valley
The Company is engaged in the Infrastructure And Utilities Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sri Chennuru, Subba Badwelu, Aitha Harishankar, and Two other members serve as directors at the Company.
- CIN/LLPIN
U01403TG2008PTC057515
- Company No.
057515
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Feb 2008
- Date of AGM
26 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Indu Genome Valley?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sri Chennuru  | Additional Director | 16-Apr-2024 | Current |
| Subba Badwelu | Additional Director | 16-Apr-2024 | Current |
| Aitha Harishankar | Director | 27-Mar-2015 | Current |
| Manvitha Chennuru | Additional Director | 16-Apr-2024 | Current |
| Gogireddy Sambareddy | Director | 05-Feb-2019 | Current |
Financial Performance of Indu Genome Valley.
Indu Genome Valley Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 100% increase in profit. The company's net worth Soared by an impressive increase of 13.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Indu Genome Valley?
In 2023, Indu Genome Valley had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vamsiram Builders And Developers Private LimitedActive 3 years 1 monthSubba Badwelu is a mutual person
Aparna Constructions And Estates Private LimitedActive 28 years 2 monthsManvitha Chennuru is a mutual person
Kakatiya Longwall Project Private LimitedActive 12 years 11 monthsSri Chennuru and Aitha Harishankar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Indu Genome Valley?
Unlock and access historical data on people associated with Indu Genome Valley, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Indu Genome Valley, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indu Genome Valley's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
